Portland, OR, April 29, 2021 (GLOBE NEWSWIRE) -- As per the report published by Allied Market Research, the global Drug-Eluting Stents Market was pegged at $6.38 billion in 2019, and is estimated to reach $8.77 billion by 2027, growing at a CAGR of 8.7% from 2020 to 2027.
Download Sample Report at: https://www.alliedmarketresearch.com/request-sample/10969
Increase in prevalence of cardiovascular disease, advent of advanced drug-eluting stents, and rise in demand for minimally invasive surgical procedures drive the growth of the global drug-eluting stents market. However, stringent government regulations hinder the market growth. On the contrary, untapped potential in the developing markets is expected to open lucrative opportunities for the market players in the future.
Covid-19 scenario:
- The Covid-19 pandemic and the followed lockdown have resulted in supply chain disruptions, presentingchallenges in several industries.
- The manufacturing and distributing companies of drug-eluting stents have been severely affected by Covid-19 pandemic. In addition, the rise in the number of Covid-19 patients has resulted in short supply of drug eluting stents.
The global drug-eluting stents market is segmented on the basis of coating, application, end user, and region. Based on coating, the polymer-free coating segment held the largest share in 2019, accounting for nearly three-fourths of the market. Moreover, the segment is estimated to register the highest CAGR of 9.1% during the forecast period.
On the basis of application, the coronary artery disease segment held the lion’s share in 2019, contributing to nearly three-fifths of the market. However, the peripheral artery disease segment is projected to manifest the highest CAGR of 9.3% during the forecast period.
Enquiry for Short-term and Long-term Impacts of COVID-19 at: https://www.alliedmarketresearch.com/purchase-enquiry/10969
The global drug-eluting stents market is analyzed across several regions such as North America, Europe, Asia-Pacific, and LAMEA. The market across North America held the largest share in 2019, accounting for nearly two-fifths of the market. However, the market across Asia-Pacific is estimated to register the highest CAGR of 10.0% during the forecast period.
The global drug-eluting stents market report include an in-depth analysis of the major market players such as Alvimedica, Abbott Laboratories, Biosensors International Group, B. Braun Holding GmbH & Co. KG, Boston Scientific Corporation, Biotronik Inc., Medtronic Plc, Cook Group (Cook Medical), Terumo Corporation, and Stentys SA.
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter
Get more information: https://www.alliedmarketresearch.com/library-access
We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.
Trending Reports [2020-2027]:
Smart Syringes Market - Global Opportunity Analysis and Industry Forecast, 2020–2027
Smart Hospitals Market - Global Opportunity Analysis and Industry Forecast, 2019-2027
Surgical Robotics Market - Global Opportunity Analysis and Industry Forecast, 2019-2027
Digital Therapeutics Market - Global Opportunity Analysis and Industry Forecast, 2019–2027
Immune Checkpoint Inhibitors Market - Global Opportunity Analysis and Industry Forecast, 2019–2027
Allergy Treatment Market - Global Opportunity Analysis and Industry Forecast, 2019–2027
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.